Topp: Difference between revisions
No edit summary |
DeEtte Starr (talk | contribs) mNo edit summary |
||
| (8 intermediate revisions by 3 users not shown) | |||
| Line 1: | Line 1: | ||
<!--Possible lab page template. To use simply copy the following text into you lab page and then replace each instance of LabName with your own lab's name--> | <!--Possible lab page template. To use simply copy the following text into you lab page and then replace each instance of LabName with your own lab's name--> | ||
{{Template:Topp}} | {{Template:Topp}} | ||
<div style="padding: 10px; width: 720px; border: 5px solid #FF4560;"> | <div style="padding: 10px; width: 720px; border: 5px solid #FF4560;"> | ||
<font size="+2">W</font>elcome | <font size="+2">W</font>elcome! | ||
<p align="left"> | <p align="left"> We study protein formulation and stability. Protein drugs are one of the fastest growing sectors of the biopharmaceutical industry, offering new treatments for difficult diseases. Proteins are fragile, though, and can degrade during manufacturing and storage. Degradation reduces drug potency and can increase the potential for serious side effects. Our goal is to develop rational methods to formulate protein drugs based on a mechanistic understanding of the degradation processes that can occur. We're particularly interested in amorphous solids. More than 40% of current protein drugs are solids, yet little is known about the factors that control reactions in the amorphous state. </p> | ||
Click the links above to learn more about our research, our group members and our recent activities. Thanks for visiting! | Click the links above to learn more about our research, our group members and our recent activities. Thanks for visiting! | ||
</div> | </div> | ||
{{Topp:end tool}} | |||
Revision as of 10:21, 3 January 2013
Welcome!
We study protein formulation and stability. Protein drugs are one of the fastest growing sectors of the biopharmaceutical industry, offering new treatments for difficult diseases. Proteins are fragile, though, and can degrade during manufacturing and storage. Degradation reduces drug potency and can increase the potential for serious side effects. Our goal is to develop rational methods to formulate protein drugs based on a mechanistic understanding of the degradation processes that can occur. We're particularly interested in amorphous solids. More than 40% of current protein drugs are solids, yet little is known about the factors that control reactions in the amorphous state.
Click the links above to learn more about our research, our group members and our recent activities. Thanks for visiting!
<html><DIV align=right> Hosted by <a href="http://www.openwetware.org"><img src="http://openwetware.org/images/0/01/80x15_openwetware.png" border=0/></a></DIV></html>
